Updates | Events | HIGHLIGHTS
Vesalius in the News
The Vesalius Team Joins the 2021 Vancouver Sun Run
The Vesalius Team joins the 2021 Vancouver Sun Run Virtual Race. This year, due to the pandemic, participants were asked to choose the circuit and the time/date to run, between April 18th and 30th. The Team chose the Stanley Park route, the epitome of Vancouver...
Vesalius Cardiovascular Reaches a New and Advanced Pre-Clinical Milestone
In a first-of-its-kind study, Vesalius proves that their catheter-based anchoring to the papillary muscle is safe and durable.
Vesalius is recognized as a Top Life Science Technology by the Ready to Rocket
March 23, 2021 - Ready to Rocket, British Columbia (BC) This annual event showcases the top technology companies that are best positioned to capitalize on the largest growth trends in the technology industry. For the fourth consecutive year, Vesalius is...
Vesalius has been selected to pitch at the LifeSciences BC Investor Summit 2020, presented by Lumira Ventures
November 2-3, 2020 - Life Sciences British Columbia, Vancouver (BC) For the 4th consecutive year, Vesalius has been selected to pitch at the LSBC Investor Summit 2020, a very select event presented by Lumira Ventures. This event was held virtually on November 2-3,...
Vesalius has been selected to pitch at the BDO Life Sciences VC Pitch Day 2020
October 2, 2020 - BDO, Canada BDO selects the best tech life sciences companies across Canada to pitch during this unique event. The Life Sciences VC Pitch Day 2020 allows up-and-coming life sciences companies to pitch their...
Vesalius joins the Canadian Technology Accelerator – Health in San Francisco
September 10, 2020 - Consulate General of Canada, San Francisco We are happy to announce our acceptance into the 2020 Canadian Technology Accelerator - Health in San Francisco. Our team will participate in this fully virtual program that includes weekly Master Classes...
Vesalius Cardiovascular Announces the Completion of a Successful Chronic Animal Study
VANCOUVER, British Columbia, January 21, 2020 (Newswire.com) Vesalius Cardiovascular Inc. (VCI), a pre-clinical stage medical device company developing novel percutaneous therapies for the treatment of mitral regurgitation, today announced the successful completion of...
Vesalius is selected to pitch at the 2019 Life Sciences British Columbia (LSBC) Investors Summit
November 6, 2019 - JW Marriott Parq Hotel, Vancouver For the third year in a row, Vesalius is selected to pitch at the LSBC Investors Summit, a regional event held to connect investor stakeholders with the healthcare innovation industry through company pitches,...
Vesalius team is attending TCT 2019 in San Francisco
September 25-29, 2019 - Moscone Convention Center, San Francisco Vesalius team is attending TCT 2019 in San Francisco. This very specialized conference is the ideal occasion to learn more about the latest therapies in interventional cardiology and connect with...
Vesalius wins top prize of $300,000 at the 2019 VGH and UBC Hospital Foundation Innovators’ Challenge
May 9, 2019 - VGH and UBC Hospital Foundation Innovators’ Challenge, Vancouver The VGH and UBC Hospital Foundation Innovators’ Challenge looks for three local medical teams involved in groundbreaking research and development to pitch their innovations to the...